首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Phellinus linteus Extract Augments the Immune Response in Mitomycin C-Induced Immunodeficient Mice.
【24h】

Phellinus linteus Extract Augments the Immune Response in Mitomycin C-Induced Immunodeficient Mice.

机译:桑黄提取物增强丝裂霉素C诱导的免疫缺陷小鼠的免疫反应。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Phellinus linteus is a fungus distributed throughout Japan, Korea and China. Boiled water-soluble extracts from P. linteus (PLW) have shown anti-tumor and immunomodulatory properties in experiments done by intraperitoneal treatment, or in in vitro cell cultures. This is the first investigation on how oral administration of PLW influences immune responses. Here, we established immunodeficient mice by mitomycin C (MMC) and then researched how PLW influenced plaque-forming cell (PFC) production and populations of cytokine [interferon- (IFNgamma-) and interleukin-4 (IL-4)]-producing T lymphocytes. PLW samples were administered orally for 19 days (1, 2 or 4 g/kg/day). PFC assay was followed using Jerne's method. IFN- and IL-4-producing T lymphocyte populations were measured by flow-activated cell sorter (FACS). These assays were conducted the day after the last oral administration. MMC groups were given MMC (1 mg/kg/day) intraperitoneally for 6 days with PLW administration. The number of PFC per 10(6) spleen cells increased significantly in the PLW (2 g/kg/day) group when compared with the MMC-control (P < 0.05) while populations of IFNgamma- and IL-4-producing T lymphocytes decreased by MMC treatment. However, the PLW group tended to increase more than the MMC-control. Our results indicated that PLW augments the immune response of the spleen in MMC-induced immunodeficient mice.
机译:桑黄(Phellinus linteus)是一种分布在日本,韩国和中国的真菌。在通过腹膜内处理或体外细胞培养进行的实验中,来自青枯假单胞菌(PLW)的煮沸的水溶性提取物已显示出抗肿瘤和免疫调节特性。这是关于口服PLW如何影响免疫反应的首次调查。在这里,我们通过丝裂霉素C(MMC)建立了免疫缺陷小鼠,然后研究了PLW如何影响噬菌斑形成细胞(PFC)的产生以及细胞因子[干扰素-(IFNgamma-)和白介素4(IL-4)]产生的T的种群淋巴细胞。口服PLW样品19天(1、2或4 g / kg /天)。使用Jerne方法进行PFC测定。通过流激活细胞分选仪(FACS)测量产生IFN和IL-4的T淋巴细胞的数量。在最后一次口服给药后的第二天进行这些测定。给MMC组腹膜内给予MMC(1 mg / kg /天),连续6天,并给予PLW。与MMC对照(P <0.05)相比,PLW(2 g / kg / day)组中每10(6)个脾细胞的PFC数量显着增加(P <0.05),而产生IFNγ和IL-4的T淋巴细胞群体通过MMC治疗降低。但是,PLW组比MMC对照组增加更多。我们的结果表明,PLW增强了MMC诱导的免疫缺陷小鼠的脾脏免疫应答。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号